Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Bioceres Crop Solutions Corp’s stock clocked out at $1.2, down -0.83% from its previous closing price of $1.21. In other words, the price has decreased by -$0.83 from its previous closing price. On the day, 0.72 million shares were traded. BIOX stock price reached its highest trading level at $1.295 during the session, while it also had its lowest trading level at $1.2.
Ratios:
To gain a deeper understanding of BIOX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.10. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 0.30.
On September 10, 2025, Canaccord Genuity Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $2.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIOX now has a Market Capitalization of 76174576 and an Enterprise Value of 347678400. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.24 while its Price-to-Book (P/B) ratio in mrq is 0.30. Its current Enterprise Value per Revenue stands at 1.093 whereas that against EBITDA is 29.443.
Stock Price History:
The Beta on a monthly basis for BIOX is 0.51, which has changed by -0.8284489 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, BIOX has reached a high of $7.23, while it has fallen to a 52-week low of $1.17. The 50-Day Moving Average of the stock is -18.09%, while the 200-Day Moving Average is calculated to be -58.28%.
Shares Statistics:
It appears that BIOX traded 534.89K shares on average per day over the past three months and 494070 shares per day over the past ten days. A total of 61.31M shares are outstanding, with a floating share count of 45.44M. Insiders hold about 28.14% of the company’s shares, while institutions hold 39.23% stake in the company. Shares short for BIOX as of 1767139200 were 1019948 with a Short Ratio of 1.91, compared to 1764288000 on 1097879. Therefore, it implies a Short% of Shares Outstanding of 1019948 and a Short% of Float of 2.75.
Earnings Estimates
Investors are keenly observing as 2.0 analysts analyze and rate. The current performance of Bioceres Crop Solutions Corp (BIOX) in the stock market.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.05 and low estimates of -$0.12. Analysts are recommending an EPS of between -$0.16 and -$0.42 for the fiscal current year, implying an average EPS of -$0.29.
Revenue Estimates
In. The current quarter, 2 analysts expect revenue to total $104.55M. It ranges from a high estimate of $113.1M to a low estimate of $96M. The current estimate, Bioceres Crop Solutions Corp’s year-ago sales were $106.8MFor the next quarter, 2 analysts are estimating revenue of $59M. There is a high estimate of $63.5M for the next quarter, whereas the lowest estimate is $54.5M.
A total of 2 analysts have provided revenue estimates for BIOX’s current fiscal year. The highest revenue estimate was $334.4M, while the lowest revenue estimate was $307.1M, resulting in an average revenue estimate of $320.75M. In the same quarter a year ago, actual revenue was $333.3M
